Release not found

Name: PPN World global press-release archive
License: https://www.ppnworld.com/legal/press-content

This press release isn’t in the live store anymore. Open the original on the wire, or jump into the live feed.

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis · Johnson & Johnson — Press Releases · PPN World